Erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression
Erratum to: Transl Cancer Res 2022;11:1565-75
In the June 2022 issue of Translational Cancer Research, the paper titled “miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression” (Transl Cancer Res 2022;11:1565-75. doi: 10.21037/tcr-21-2419) (1), was published with some errors in Figure 1C and Figure 5C. When editing PDF image file, the authors mistakenly placed the image from the miR-Vector group in the Ctrl group in Figure 1C; and placed the image from the Ctrl group in the Scrambler group in Figure 5C. The figure legends remain intact.
The whole Figure 1 should be corrected as:
The whole Figure 5 should be corrected as:
The authors confirmed that these corrections do not change the description or original conclusions of the paper and sincerely apologize for any inconvenience caused by these mistakes.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
- Wang Z, Jing X, Li F, et al. miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression. Transl Cancer Res 2022;11:1565-75. [Crossref] [PubMed]